|
|
|
Volumn 37, Issue 2, 2003, Pages
|
|
The estrogen and progestin dilemma: New advice, labeling guidelines
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CONJUGATED ESTROGEN;
CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE;
MEDROXYPROGESTERONE ACETATE;
ARTICLE;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
DRUG COMBINATION;
DRUG LABELING;
ESTROGEN THERAPY;
FEMALE;
FOOD AND DRUG ADMINISTRATION;
HEART DISEASE;
HOT FLUSH;
HUMAN;
POSTMENOPAUSE;
PRACTICE GUIDELINE;
STANDARD;
THROMBOSIS;
UNITED STATES;
BREAST NEOPLASMS;
DRUG COMBINATIONS;
DRUG LABELING;
ESTROGEN REPLACEMENT THERAPY;
ESTROGENS, CONJUGATED (USP);
FEMALE;
GUIDELINES;
HEART DISEASES;
HOT FLASHES;
HUMANS;
MEDROXYPROGESTERONE 17-ACETATE;
POSTMENOPAUSE;
THROMBOSIS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0037505781
PISSN: 03621332
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (5)
|
|
References (0)
|